Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J-P Cassuto

BCR-ABLT315I Transcript Disappearance in an Imatinib-Resistant CML Patient Treated With Homoharringtonine: A New Therapeutic Challenge?

Leukemia

English

Cathepsin B Release After Imatinib-Mediated Lysosomal Membrane Permeabilization Triggers BCR–ABL Cleavage and Elimination of Chronic Myelogenous Leukemia Cells

English

Related publications

Coexistence of AML1/RUNX1 and BCR-ABL Point Mutations in an Imatinib-Resistant Form of CML

English

Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML

International Journal of Human Genetics

Genetics

2019

English

Resistant Hypertension: A Therapeutic Challenge

Journal of Clinical Hypertension

Internal Medicine

Cardiology

Endocrinology

Cardiovascular Medicine

Metabolism

Diabetes

2018

English

A Novel BCR-Abl Splice Isoform Is Associated With the L248V Mutation in CML Patients With Acquired Resistance to Imatinib

English

Concamitant Expression of the Rare E1/A3 and B2/A3 Types of BCR/ABL Transcript in a Chronic Myeloid Leukemia (CML) Patient

English

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

English

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy

Gastroenterology

2009

English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

English

Generalized Pustular Psoriasis in an Adolescent Treated With Cyclosporine: A Diagnostic and Therapeutic Challenge

SKIN The Journal of Cutaneous Medicine

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J-P Cassuto

BCR-ABLT315I Transcript Disappearance in an Imatinib-Resistant CML Patient Treated With Homoharringtonine: A New Therapeutic Challenge?

Cathepsin B Release After Imatinib-Mediated Lysosomal Membrane Permeabilization Triggers BCR–ABL Cleavage and Elimination of Chronic Myelogenous Leukemia Cells

Related publications

Coexistence of AML1/RUNX1 and BCR-ABL Point Mutations in an Imatinib-Resistant Form of CML

Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML

Resistant Hypertension: A Therapeutic Challenge

A Novel BCR-Abl Splice Isoform Is Associated With the L248V Mutation in CML Patients With Acquired Resistance to Imatinib

Concamitant Expression of the Rare E1/A3 and B2/A3 Types of BCR/ABL Transcript in a Chronic Myeloid Leukemia (CML) Patient

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Generalized Pustular Psoriasis in an Adolescent Treated With Cyclosporine: A Diagnostic and Therapeutic Challenge